Breaking News Instant updates and real-time market news.

DIS

Disney

$102.87

-0.37 (-0.36%)

, AGN

Allergan

$168.96

2.84 (1.71%)

20:01
03/18/18
03/18
20:01
03/18/18
20:01

On The Fly: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Data analytics firm Cambridge Analytica harvested private information from more than 50M Facebook (FB) users in developing techniques to support President Donald Trump's 2016 election campaign, according to The New York Times. Several U.S. Republican lawmakers have expressed concern over privacy violations after the news report. 2. CACI International (CACI) announced that it has made a proposal to acquire all outstanding shares of CSRA (CSRA) for $44.00 per share in cash and stock. CACI's proposal includes a cash component of $15 per share and a stock component in the form of CACI stock at a fixed exchange ratio of 0.184 shares of CACI common stock for each share of CSRA stock. The acquisition proposal represents an 8% premium over the price CSRA's shareholders would receive in the announced transaction with General Dynamics (GD). CACI also raised its FY18 EPS outlook to $11.26-$11.50 from $10.95-$11.19, and its FY18 revenue forecast to $4.4B-$4.5B from $4.35B-$4.5B. 3. Old Navy is enjoying fast sales growth and plump profit margins but is trapped inside Gap (GPS), a name that has been an investor turnoff, Jack Hough wrote in this week's edition of Barron's. Old Navy contributes close to half of company sales and within two years could generate three-quarters of profits, and yet Gap shares trade at just 12 times projected earnings for the next four quarters, which is one sign Gap could have plenty of upside left - perhaps 25% or more over the coming year, he added. 4. Disney (DIS) and Marvel Studios' "Black Panther" continues to make history in its fifth weekend at the domestic box office with another $27M. The superhero film, which scored 97% from Rotten Tomatoes and got an A+ CinemaScore from movie audiences, is only the seventh movie ever to cross the $600M mark in North America. 5. Allergan (AGN) saw a positive mention in Barron's.

DIS

Disney

$102.87

-0.37 (-0.36%)

AGN

Allergan

$168.96

2.84 (1.71%)

GPS

Gap

$31.74

-0.09 (-0.28%)

FB

Facebook

$185.09

1.23 (0.67%)

CACI

CACI

$157.45

3.3 (2.14%)

CSRA

CSRA

$40.65

-0.02 (-0.05%)

GD

General Dynamics

$222.74

0.14 (0.06%)

  • 18

    Mar

  • 19

    Mar

  • 22

    Mar

  • 25

    Mar

  • 05

    Apr

  • 11

    Apr

  • 24

    Apr

DIS Disney
$102.87

-0.37 (-0.36%)

03/15/18
LOOP
03/15/18
INITIATION
Target $130
LOOP
Buy
Disney initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started Disney (DIS) with a Buy rating and $130 price target. The analyst views the Disney/21st Century Fox (FOXA) deal as a "win/win," positioning Disney to be a more competitive player in the global streaming business.
03/09/18
BTIG
03/09/18
NO CHANGE
BTIG
Disney able, but unwilling, to go 'all-in' to win streaming war, says BTIG
BTIG analyst Richard Greenfield believes Disney (DIS) has the content and balance sheet strength to "win" the streaming wars against Netflix (NFLX) and others if it were willing to go "all-in" on digital, but the company appears unwilling to do so. By "all-in," Greenfield says he means making every new theatrical release from Disney available on their streaming service day and date with its theatrical release. Such an aggressive strategy would be how Disney could 'win the streaming wars, rather than dipping their toe in the water of streaming while trying to "milk" their legacy business models,' Greenfield contends in a new note to investors.
03/14/18
MACQ
03/14/18
UPGRADE
MACQ
Outperform
Sky upgraded to Outperform from Neutral at Macquarie
Macquarie analyst Guy Peddy upgraded Sky (SKYAY) to Outperform from Neutral after he raised his FY19/20 and FY20/21 EPS by about 16% due to the lower EPL costs. His valuation analysis suggests the current 1075p offer from 21st Century Fox (FOXA) "materially undervalues" Sky and even Comcast's (CMCSA) indicative offer at 1250p "fractionally undervalues" it, Peddy tells investors. What happens next is up to Comcast and Disney (DIS), as Fox is just an intermediary, he added. Peddy raised his price target on Sky shares to 1450p, as he believes tension between those two could lift the offer price at least 10% above his fair value estimate of 1287p.
03/15/18
LOOP
03/15/18
INITIATION
Target $43
LOOP
Buy
21st Century Fox initiated with a Buy at Loop Capital
Loop Capital analyst Alan Gould started 21st Century Fox (FOXA) with a Buy rating and $43 price target. The analyst believes the company is set up as the "ideal acquisition target for either Disney (DIS) or Comcast (CMCSA) as they evolve their video businesses into a global, direct-to-consumer streaming service."
AGN Allergan
$168.96

2.84 (1.71%)

03/05/18
RHCO
03/05/18
INITIATION
Target $24
RHCO
Buy
Evolus initiated with a Buy at SunTrust
SunTrust analyst John Boris initiated Evolus (EOLS) with a Buy rating and a price target of $24. Boris notes that the company is about its launch it first product DWP-450, targeting the $2B global aesthetic toxin market, adding that the treatment has been de-risked with comparable efficacy to Allergan's (AGN) Botox. The analyst anticipates regulatory approval from the FDA and a soft U.S. launch in Q4 of this year.
03/14/18
RBCM
03/14/18
NO CHANGE
RBCM
Outperform
RBC says Allergan sent clear message that all strategic options being evaluated
RBC Capital analyst Randall Stanicky said that Allergan Chairman and CEO Brent Saunders and new CFO Matt Walsh sent a "clear" message while presenting earlier at an investor conference that all strategic options are being evaluated "with a sense of urgency." This message, which he said is the one he had hoped to hear, will keep the asset sale/break-up debate in the stock, said Stanicky. The analyst, who expects the Street's focus on asset sales to pick up following this, keeps an Outperform rating on Allergan shares.
03/15/18
JPMS
03/15/18
NO CHANGE
Target $265
JPMS
Overweight
Allergan CEO comments on evaluating options a 'clear positive,' says JPMorgan
JPMorgan analyst Chris Schott views Allergan CEO Brent Saunders' comments yesterday on evaluating all options to create value as a "clear positive." The company is focusing on core business execution with a set of near-term pipeline opportunities while also examining other potential value-unlocking options for the business, Schott tells investors in a research note. The analyst says he has long argued that Allergan's core business is "significantly undervalued" and that any shift toward greater Botox/aesthetics exposure would result in a company that trades at a "distinctly higher multiple" than the current business. As such, he believes selling or spinning off assets could unlock value. Schott keeps an Overweight rating on Allergan with a $265 price target.
03/05/18
CANT
03/05/18
INITIATION
Target $25
CANT
Overweight
Evolus initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen started Evolus (EOLS) with an Overweight rating and $25 price target. Physicians want a less costly alternative to Allergan's (AGN) Botox, Chen tells investors in a research note. She expects approval of DWP-450 before the end of the year and notes Evolus is planning to sell the neurotoxin at a 20%-25% discount to Botox.
GPS Gap
$31.74

-0.09 (-0.28%)

03/02/18
BMOC
03/02/18
NO CHANGE
Target $35
BMOC
Market Perform
Gap price target raised to $35 from $29 at BMO Capital
BMO Capital analyst John Morris raised his price target on Gap to $35 after the company's Q4 beat on earnings, revenue, and gross margins. Morris keeps his Market Perform rating on the stock however, pointing to a 9% rise in inventories and warns that gross margins could be pressured in the near term as the company works through its "sizable inventory overhang of likely out-of-season product". Among the positives, the analyst cites the company's use of data analytics to develop a "customer moat" in product and also points to Gap's digital channel growth of 30% in Q4.
03/09/18
OPCO
03/09/18
NO CHANGE
Target $33
OPCO
Perform
Gap price target raised to $33 from $30 at Oppenheimer as firm stays sidelined
Oppenheimer analyst Anna Andreeva raised her price target on Gap to $33 from $30, telling investors in a research note that she is staying "sidelined" on Gap and expects a "skewed recovery" in the business in the second half of 2018. Andreeva, who has a Perform rating on Gap, said despite "impressive" momentum at Old Navy, she expects challenges at the Gap division to continue and sees pressures from promotions and inventory imbalance through the first half of the year. In order for shares to "work," the analyst said an inflection at Gap and Banana Republic is necessary, but doesn't see this happening until the second half "at the earliest."
03/12/18
FBCO
03/12/18
INITIATION
Target $35
FBCO
Neutral
Gap initiated with a Neutral at Credit Suisse
Credit Suisse initiated Gap with a Neutral and $35 price target.
03/02/18
MKMP
03/02/18
NO CHANGE
Target $35
MKMP
Neutral
Gap price target raised to $35 from $27 at MKM Partners
MKM Partners analyst Roxanne Meyer raised her price target on Gap to $35 after the company's Q4 results showed better than expected comps and a "significantly higher gross margin increase". Meyer adds that the comps at each segment accelerated on a 2-year stock, while traffic trends were also improved. The analyst keeps her Neutral rating on the stock, preferring to wait for better visibility that the strength of Old Navy and the shift toward higher performing concepts will "unlock earnings power" this year.
FB Facebook
$185.09

1.23 (0.67%)

02/22/18
DADA
02/22/18
NO CHANGE
Target $55
DADA
Buy
Applied Optoelectronics price target lowered to $55 from $69 at DA Davidson
DA Davidson analyst Mark Kelleher lowered his price target on Applied Optoelectronics (AAOI) to $55 following a miss on Q4 revenue and lower than expected Q1 guidance. The analyst attributes the miss to a sequential decline in gross margins due to reduced capacity utilization and price cuts, while also modeling a weaker 40GB/100GB demand in his price target going forward. Kelleher keeps his Buy rating on Applied Optoelectronics, thanks in part to an incremental positive of its recent supply agreement with Facebook (FB), with the revenue ramp from the contract expected in the second half of this year.
03/13/18
JEFF
03/13/18
NO CHANGE
Target $1850
JEFF
Buy
Jefferies boosts Amazon target to $1,850 after ad business deep dive
Following a deep dive into the company's advertising business, Jefferies analyst Brent Thill raised his price target for Amazon.com (AMZN) shares to $1,850 from $1,750. The stock closed yesterday up $19.50 to $1,589.39. Amazon's ad segment should grow annually at 43% to $22B by 2022, Thill tells investors in a research note. Amazon is aggressively growing its advertising business, but not at the expense of Facebook (FB) and Google (GOOG, GOOGL), the analyst contends. He says Amazon's "billions of touch points with consumers and end of funnel sales conversion are an advertiser's dream for targeting and attribution." Thill thinks the "right pieces are in place" for Amazon to get to $1 trillion in market capitalization over time. He keeps a Buy rating on Amazon shares.
03/13/18
MSCO
03/13/18
NO CHANGE
MSCO
Morgan Stanley compares automakers to Facebook, Apple in 'Auto 2.0' model
Morgan Stanley analyst Adam Jonas noted that auto companies' valuations have compressed to extremely low levels, but he believes that a move from a vehicle ownership model to a transportation subscriber model could expand the revenue opportunities for the potential "tollkeepers" for the monetization of content and data by "nearly an order of magnitude." Looking at U.S. technology leaders Facebook (FB) and Apple (AAPL), which are both valued on their installed base/subscriber models, can "offer valuable clues" regarding the opportunity for General Motors (GM) and other auto OEMs, said Jonas. Viewing the OEMs though the lens of a subscription model, which should be less cyclical and potentially less capital intensive over time than the current auto model, is relevant to analyzing auto stocks, according to Jonas, who adds that it is still too early to call a winner or loser in "Auto 2.0." Other publicly traded legacy automakers include Fiat Chrysler (FCAU), Ford (F), Honda (HMC), Nissan (NSANY), Toyota (TM), Volkswagen (VLKAY) and Daimler (DDAIF).
03/06/18
DADA
03/06/18
NO CHANGE
Target $55
DADA
Buy
Market undervalues Applied Optoelectronics deal with Facebook, says DA Davidson
DA Davidson analyst Mark Kelleher writes that his recent meetings with the management of Applied Optoelectronics (AAOI) suggests that investors underappreciate the impact of its $125M deal with Facebook (FB). The analyst notes that the deal gives the company some added visibility for the second half of 2018 and is also a sign that Facebook acknowledges the possibility of a transceiver shortage by the end of the year. Kelleher keeps his Buy rating and $55 price target on Applied Optoelectronics.
CACI CACI
$157.45

3.3 (2.14%)

02/01/18
LOOP
02/01/18
UPGRADE
Target $170
LOOP
Buy
CACI upgraded to Buy from Hold at Loop Capital
Loop Capital analyst Joseph Vafi upgraded CACI International to Buy and raised his price target for the shares to $170 from $140. The analyst says he can't ignore the "almost dollar-for-dollar boost" to CACI's net income due to tax reform. He believes Street estimates have to move up "materially" following last night's Q2 results.
02/12/18
SBSH
02/12/18
NO CHANGE
SBSH
Citi sees services stocks outperforming after CSRA buyout
Citi analyst Jonathan Raviv expects government service stocks to outperform after General Dynamics (GD) announced its acquisition of CSRA (CSRA) for $9.6B. The analyst notes he has Buy ratings on Leidos (LDOS), CACI (CACI), SAIC (SAIC) and a Neutral rating on Booz Allen (BAH). Raviv, however, can't think of another prime interested in consolidating more services. The analyst also expects Buy-rated Harris (HRS) to underperform today as he thinks there was some takeout speculation baked into shares.
02/02/18
NBLE
02/02/18
DOWNGRADE
Target $153
NBLE
Hold
CACI downgraded to Hold on valuation at Noble Financial
Noble Financial downgraded CACI to Hold from Buy with a $153 price target citing valuation.
02/02/18
MAXM
02/02/18
NO CHANGE
Target $174
MAXM
Buy
CACI price target raised to $174 from $159 at Maxim
Maxim analyst Brian Kinstlinger raised his price target on CACI to $174 after the company's Q2 earnings beat thanks to stronger-than-expected award fees as well as a better performance on fixed price programs. The analyst expects revenue growth to be sustainable, with the company having been awarded about $1.1B in contracts during Q2, while keeping his Buy rating on CACI.
CSRA CSRA
$40.65

-0.02 (-0.05%)

02/20/18
RBCM
02/20/18
NO CHANGE
Target $267
RBCM
Outperform
General Dynamics price target raised to $267 from $258 at RBC Capital
RBC Capital analyst Matthew McConnell raised his price target on General Dynamics (GD) to $267, saying the company's acquisition of CSRA (CSRA) is a "savvy deal in a core and high ROIC platform of a best-in-class asset at a reasonable price". The analyst keeps his Outperform rating on General Dynamics, noting that CSRA is on the cusp of organic revenue growth acceleration after posting a book-to-bill of at least 1.3-times over the past ten quarters.
02/15/18
LOOP
02/15/18
DOWNGRADE
Target $40.75
LOOP
Hold
CSRA downgraded to Hold from Buy at Loop Capital
Loop Capital analyst Joseph Vafi downgraded CSRA (CSRA) to Hold while raising his price target for the shares to $40.75 from $37 to reflect the acquisition by General Dynamics (GD). The analyst sees "slim" chances of a higher takeover offer emerging.
02/14/18
RHCO
02/14/18
DOWNGRADE
Target $40.75
RHCO
Hold
CSRA downgraded to Hold from Buy at SunTrust
SunTrust analyst Frank Atkins downgraded CSRA (CSRA) to Hold from Buy but raised his price target to $40.75 from $39 after a bid from General Dynamics (GD). Atkins contends that the deal will likely proceed "in a smooth manner" and is unlikely to be topped, noting that CEO Larry Prior has likely evaluated several options in the context of shareholder value before agreeing to General Dynamics deal.
02/26/18
COWN
02/26/18
NO CHANGE
Target $253
COWN
Outperform
General Dynamics price target raised to $253 from $230 at Cowen
Cowen analyst Cai von Rumohr raised his price target on General Dynamics (GD) and said it is now his number one defense pick. The analyst cited improving business jet demand, the strongest 2019 Department of Defense budget request, and the accretive CSRA (CSRA) acquisition. von Rumohr reiterated his Outperform rating on General Dynamics shares.
GD General Dynamics
$222.74

0.14 (0.06%)

03/02/18
BERN
03/02/18
NO CHANGE
Target $255
BERN
Outperform
Raytheon remains 'top pick' in defense sector, says Bernstein
Bernstein analyst Douglas Harned continues to view Raytheon (RTN) as his "top pick" in the defense space in light of recent Q4 results and progress on the defense budget, which is "more positive" following an agreement in Congress on budget top lines for FY18 and FY19, and publication of a President's budget request for FY19. In a research note to investors, Harned said that while yesterday's announcement of 25% tariffs on steel and 10% on aluminum is negative, most defense contracts should be protected by long-term agreements. Raytheon's business mix, with 40% of revenues coming from missile defense and tactical missiles, looks "most positive," he said, but noted that other defense names, including General Dynamics (GD), Huntington Ingalls (HII), Lockheed Martin (LMT) and Northrop Grumman (NOC), are all rated Market Perform given high valuations.

TODAY'S FREE FLY STORIES

IJR

iShares Core S&P Small Cap ETF

$86.82

-0.4 (-0.46%)

06:41
08/14/18
08/14
06:41
08/14/18
06:41
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VERU

Veru Inc.

$2.06

-0.1 (-4.63%)

06:40
08/14/18
08/14
06:40
08/14/18
06:40
Earnings
Veru reports Q3 EPS (15c), consensus (8c) »

Reports Q3 revenue $5.5M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

EEM

MSCI Emerging Markets Index

$42.50

-0.695 (-1.61%)

06:39
08/14/18
08/14
06:39
08/14/18
06:39
Technical Analysis
MSCI Emerging Markets Index: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EYEN

Eyenovia

$5.55

-0.1 (-1.77%)

06:39
08/14/18
08/14
06:39
08/14/18
06:39
Earnings
Eyenovia reports Q2 EPS (33c), consensus (42c) »

Reports Q2 revenue $0,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

MSFT

Microsoft

$108.24

-0.81 (-0.74%)

, AMZN

Amazon.com

$1,895.51

9.52 (0.50%)

06:39
08/14/18
08/14
06:39
08/14/18
06:39
Periodicals
Microsoft still trying to find Cortana's voice, WSJ reports »

Microsoft (MSFT) is…

MSFT

Microsoft

$108.24

-0.81 (-0.74%)

AMZN

Amazon.com

$1,895.51

9.52 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 04

    Sep

  • 12

    Sep

  • 13

    Sep

EWW

iShares MSCI Mexico

$49.56

-0.065 (-0.13%)

06:39
08/14/18
08/14
06:39
08/14/18
06:39
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUP

PowerShares DB US Dollar Index Up

$25.50

0.01 (0.04%)

06:38
08/14/18
08/14
06:38
08/14/18
06:38
Technical Analysis
PowerShares DB US Dollar Index Up: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDN

PowerShares DB US Dollar Index Down

$21.24

-0.01 (-0.05%)

06:38
08/14/18
08/14
06:38
08/14/18
06:38
Technical Analysis
PowerShares DB US Dollar Index Down: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SESN

Sesen Bio

$1.89

0.09 (5.00%)

06:37
08/14/18
08/14
06:37
08/14/18
06:37
Earnings
Sesen Bio reports Q2 EPS (16c), consensus (14c) »

Reports Q2 revenue $0,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$17.77

(0.00%)

06:36
08/14/18
08/14
06:36
08/14/18
06:36
Hot Stocks
Chaparral raises FY18 average daily production view to 19.0MBoe/d-20.0MBoe/d »

Previous FY18 average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

UHS

Universal Health

$124.44

-0.01 (-0.01%)

06:36
08/14/18
08/14
06:36
08/14/18
06:36
Initiation
Universal Health initiated  »

Universal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THC

Tenet

$32.54

0.28 (0.87%)

06:35
08/14/18
08/14
06:35
08/14/18
06:35
Initiation
Tenet initiated  »

Tenet initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$194.11

-2.19 (-1.12%)

06:35
08/14/18
08/14
06:35
08/14/18
06:35
Technical Analysis
Technical Take: Home Depot moves higher after results »

The shares were last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

06:35
08/14/18
08/14
06:35
08/14/18
06:35
Hot Stocks
Advance Auto Parts announces new $600M share repurchase program »

On August 8, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

HCA

HCA Healthcare

$128.74

0.57 (0.44%)

06:35
08/14/18
08/14
06:35
08/14/18
06:35
Initiation
HCA Healthcare initiated  »

HCA Healthcare initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

MMS

Maximus

$63.51

0.24 (0.38%)

06:35
08/14/18
08/14
06:35
08/14/18
06:35
Hot Stocks
Maximus receives North Carolina DHHS contract to provide Medicaid services »

Maximus announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYH

Community Health

$3.15

0.06 (1.94%)

06:34
08/14/18
08/14
06:34
08/14/18
06:34
Initiation
Community Health initiated  »

Community Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 22

    Aug

CHAP

Chaparral Energy

$17.77

(0.00%)

06:33
08/14/18
08/14
06:33
08/14/18
06:33
Earnings
Chaparral Energy reports Q2 EPS (49c) with items, consensus 9c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

06:33
08/14/18
08/14
06:33
08/14/18
06:33
Earnings
Advance Auto Parts sees FY18 revenue $9.3B-$9.5B, consensus $9.38B »

Sees FY18 SSS growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

SYY

Sysco

$72.72

4.31 (6.30%)

06:32
08/14/18
08/14
06:32
08/14/18
06:32
Recommendations
Sysco analyst commentary  »

Sysco price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

06:31
08/14/18
08/14
06:31
08/14/18
06:31
Hot Stocks
Breaking Hot Stocks news story on Advance Auto Parts »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

06:30
08/14/18
08/14
06:30
08/14/18
06:30
Hot Stocks
Breaking Hot Stocks news story on Advance Auto Parts »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

06:30
08/14/18
08/14
06:30
08/14/18
06:30
Earnings
Advance Auto Parts reports Q2 adjusted EPS $1.97, consensus $1.86 »

Reports Q2 revenue $2.3B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

PERI

Perion Network

$1.00

-0.0501 (-4.77%)

06:30
08/14/18
08/14
06:30
08/14/18
06:30
Initiation
Perion Network initiated  »

Perion Network initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTX

Aptinyx

$22.48

0.48 (2.18%)

06:29
08/14/18
08/14
06:29
08/14/18
06:29
Earnings
Aptinyx reports Q2 EPS ($1.83), consensus (48c) »

Reports Q2 revenue $2.1M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.